PMID: 2881039Feb 28, 1987

Herpes-virus immunity and acute graft-versus-host disease

J W GratamaJ M Vossen


The influence of pretransplant herpes-virus antibodies in 126 marrow-graft recipients and their HLA-identical (A, B, C, DR) sibling donors on the incidence of grades II-IV acute graft-versus-host disease (GVHD) was studied in relation to previously reported risk factors for GVHD. Logistic regression procedures were used to control for confounding factors. Increasing donor age (odds ratio 3.7 per decade; p = 0.02) and donor seronegativity for Epstein-Barr virus (EBV; odds ratio 10.1; p = 0.005) were associated with a high incidence of GVHD. Total rather than selective gastrointestinal decontamination (odds ratio 0.1; p = 0.004), donor seronegativity for herpes simplex virus (HSV; odds ratio 0.1; p = 0.003), and recipient EBV-seronegativity (odds ratio 0.05; p = 0.002) were associated with a low incidence of GVHD. Pretransplant EBV and HSV serology may thus contribute substantially to the estimation of the risk for GVHD.


Oct 1, 1979·The Journal of Infectious Diseases·A C HekkerR C Meijers
Apr 17, 1975·The New England Journal of Medicine·E D ThomasC D Buckner
Apr 24, 1975·The New England Journal of Medicine·E D ThomasC D Buckner
Sep 1, 1975·Southern Medical Journal·A H Ragab
Jan 15, 1985·International Journal of Cancer. Journal International Du Cancer·Q Y YaoM A Epstein
Jan 15, 1985·International Journal of Cancer. Journal International Du Cancer·Q Y YaoM A Epstein
Dec 1, 1981·International Journal of Cancer. Journal International Du Cancer·D H CrawfordG Janossy
Oct 1, 1983·Clinics in Haematology·K M Sullivan, R Parkman
Oct 1, 1984·The American Journal of Medicine·B R BlazarP B McGlave
Jan 1, 1984·Survey and Synthesis of Pathology Research·W E Beschorner
Feb 19, 1981·The New England Journal of Medicine·M De WaeleB K Van Camp
Feb 18, 1982·The New England Journal of Medicine·N K RamsayM E Nesbit
Jun 24, 2000·Clinical Journal of Oncology Nursing·M E O'Rourke, K High
Apr 10, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S K P LauK Y Yuen
Apr 1, 1985·Immunology Today·G Trinchieri, B Perussia


Nov 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S M Devine, J R Wingard
Jan 1, 1987·Immunology Today·G C de GastE Gluckman
May 18, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·K RoubalováJ Sajdová
May 19, 2010·Bone Marrow Transplantation·D D PoutsiakaD R Snydman
Sep 1, 1993·Journal of Clinical Pathology·A L Appleton, L Sviland
Feb 1, 1995·Journal of Clinical Pathology·C FeganJ A Whittaker
Mar 1, 1994·Journal of Medical Virology·E CantinE McLaughlin-Taylor
Jan 1, 1993·Journal of Medical Virology·R Saral
Jan 1, 1990·Springer Seminars in Immunopathology·G J Cox, G B McDonald
Feb 20, 1991·International Journal of Cancer. Journal International Du Cancer·D T PurtiloK W Beisel
Aug 30, 2020·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Anna B PawlowskaJoseph Rosenthal

Related Concepts

Acute Disease
Antibodies, Viral
Epstein-Barr Virus
Graft-vs-Host Disease
Thymic Group Viruses
Bone Marrow Cell Transplantation

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.